Harvard Bioscience (HBIO) Price & Analysis

Compare

241 Followers

HBIO Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.28 - $3.04

Previous CloseN/A

Volume27.75K

Average Volume (3M)649.28K

Market Cap

$21.78M

Enterprise Value$55.53M

Total Cash (Recent Filing)$7.44M

Total Debt (Recent Filing)$43.31M

Price to Earnings (P/E)―

Beta1.81

Next Earnings

Nov 06, 2025

EPS Estimate

0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding44,531,197

10 Day Avg. Volume504,875

30 Day Avg. Volume649,284

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap2.55

Enterprise Value/Revenue0.63

Enterprise Value/Gross Profit1.13

Enterprise Value/Ebitda-1.19

Forecast

1Y Price Target

$1.75

Price Target Upside272.34% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

EarningsHarvard Bioscience pre-announced better than expected 2Q revenue of approximately $20.4 million.

Operational EfficiencyCost cutting is expected to reduce operating expenses by $1 million a quarter going forward, overcoming cautious revenue expectations.

Product InnovationManagement remains optimistic about the 2025 prospects for newly launched products such as cellular organ models and large-scale electroporation, which offer higher margins and a proportionately higher recurring revenue stream.

Bears Say

Financial RiskHBIO recently violated the consolidated net leverage ratio covenant and is now operating under a waiver from its lenders.

Leadership ChangesCEO and Chairman Jim Green would be retiring after more than eight years as Chairman and six years as President & CEO.

Market ChallengesThe outlook for end-user markets in biomedical research continues to be challenging due to uncertainty around China tariffs, NIH funding, and biopharmaceutical research activity.

Harvard Bioscience News

Harvard Bioscience reports Q2 adjusted EPS (1c) vs. 0c last year

Reports Q2 revenue $20.5M vs. $23.1M last year. “We made solid progress in the second quarter exceeding our...

26d ago

HBIO

Harvard Bioscience sees Q3 revenue $19M-$21M

07:03 EDT Harvard Bioscience (HBIO) sees Q3 revenue $19M-$21M Published first on TheFly – the ultimate source for...

26d ago

HBIO

Harvard Bioscience enters amendment to credit agreement

The Company entered into an amendment to its credit agreement. Pursuant to the amendment, the lenders have agreed...

26d ago

HBIO

Harvard Bioscience Offers CFO $100K Retention Bonus

An update from Harvard Bioscience ( ($HBIO) ) is now available. On August 12, 2025, Harvard Bioscience, Inc....

23d ago

HBIO

Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability

Harvard Bioscience (HBIO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Harvard Bioscience...

24d ago

HBIO

Harvard Bioscience Reports Q2 2025 Financial Results

Harvard Bioscience ( ($HBIO) ) has released its Q2 earnings. Here is a breakdown of the information Harvard...

25d ago

HBIO

Harvard Bioscience Surpasses Revenue Guidance Amid Challenges

Harvard Bioscience (($HBIO)) has held its Q2 earnings call. Read on for the main highlights of the call....

25d ago

HBIO

Harvard Bioscience Amends Credit Agreement with Lenders

Harvard Bioscience ( ($HBIO) ) has shared an update. On August 8, 2025, Harvard Bioscience, Inc. entered into...

25d ago

HBIO

HBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Harvard Bioscience (HBIO) is scheduled to report 2nd quarter earnings on 08/06/2025. Regarding Q2 estimates, Wall Street analysts...

1M ago

HBIO

Harvard Bioscience: Strong Q2 Performance and Strategic Leadership Changes Drive Buy Rating

Harvard Bioscience, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Bruce Jackson from...

2M ago

HBIO

Harvard Bioscience Announces CEO Succession Plan

An update from Harvard Bioscience ( ($HBIO) ) is now available. On July 17, 2025, Harvard Bioscience announced...

2M ago

HBIO

Harvard Bioscience announces CEO succession plan, appointment of two directors

Harvard Bioscience (HBIO) announced a CEO succession plan under which John Duke will assume the role of President...

2M ago

HBIO

Harvard Bioscience Faces Nasdaq Compliance Challenge

Harvard Bioscience ( ($HBIO) ) has issued an update. On June 18, 2025, Harvard Bioscience, Inc. informed Nasdaq...

2M ago

HBIO

Harvard Bioscience Approves Incentive Plan Amendment

Harvard Bioscience ( ($HBIO) ) has issued an update. On May 30, 2025, Thomas Loewald resigned from the...

3M ago

HBIO

HBIO FAQ

What was Harvard Bioscience’s price range in the past 12 months?

Harvard Bioscience lowest stock price was $0.28 and its highest was $3.04 in the past 12 months.

What is Harvard Bioscience’s market cap?

Harvard Bioscience’s market cap is $21.78M.

When is Harvard Bioscience’s upcoming earnings report date?

Harvard Bioscience’s upcoming earnings report date is Nov 06, 2025 which is in 61 days.

How were Harvard Bioscience’s earnings last quarter?

Harvard Bioscience released its earnings results on Aug 11, 2025. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.025 by $0.015.

Is Harvard Bioscience overvalued?

According to Wall Street analysts Harvard Bioscience’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Harvard Bioscience pay dividends?

Harvard Bioscience does not currently pay dividends.

What is Harvard Bioscience’s EPS estimate?

Harvard Bioscience’s EPS estimate is 0.01.

How many shares outstanding does Harvard Bioscience have?

Harvard Bioscience has 44,531,197 shares outstanding.

What happened to Harvard Bioscience’s price movement after its last earnings report?

Harvard Bioscience reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.025. Following the earnings report the stock price went down -9.434%.

Which hedge fund is a major shareholder of Harvard Bioscience?

Currently, no hedge funds are holding shares in HBIO

Harvard Bioscience Stock Smart Score

Neutral

Fundamentals

Return on Equity

-138.36%

Trailing 12-Months

Asset Growth

-37.87%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Harvard Bioscience

Harvard Bioscience (HBIO) is a global provider of innovative tools, instruments, and consumables for life science research. The company operates primarily in the biotechnology and pharmaceutical sectors, offering a wide range of products that facilitate research in areas such as drug discovery, neuroscience, and regenerative medicine. Core products include laboratory instruments, precision measurement devices, and advanced technologies for cellular and molecular biology applications.

Harvard Bioscience (HBIO) Earnings & Revenues

Historic Earnings Reports

HBIO Company Deck

HBIO Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call revealed a mixed performance with some positive developments such as exceeding revenue guidance, strong cash flow, and new product launches, while facing challenges like year-over-year revenue decline and impacts from NIH funding delays and tariffs. However, the company has shown resilience by implementing cost efficiencies and addressing debt obligations.View all HBIO earnings summaries

HBIO Stock 12 Month Forecast

Average Price Target

$1.75

▲(272.34% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","-1":"-$1","0.75":"$0.75","2.5":"$2.5","4.25":"$4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.683076923076923,0.8761538461538461,1.0692307692307692,1.2623076923076924,1.4553846153846153,1.6484615384615384,1.8415384615384613,2.0346153846153845,2.2276923076923074,2.4207692307692303,2.6138461538461533,2.806923076923077,{"y":3,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.5869230769230769,0.6838461538461538,0.7807692307692308,0.8776923076923077,0.9746153846153846,1.0715384615384616,1.1684615384615384,1.2653846153846153,1.3623076923076922,1.459230769230769,1.556153846153846,1.653076923076923,{"y":1.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.49076923076923074,0.49153846153846154,0.4923076923076923,0.4930769230769231,0.4938461538461538,0.4946153846153846,0.49538461538461537,0.49615384615384617,0.4969230769230769,0.4976923076923077,0.49846153846153846,0.49923076923076926,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.69,"date":1685577600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.35,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.08,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.11,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >